UNSPSC 51241104: Brinzolamide

This classification denotes a carbonic anhydrase inhibitor and anti-glaucoma agent with the molecular formula C12H21N3O5S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9451Z89515, chemically known as 2h-thieno(3,2-e)-1,2-thiazine-6-sulfonamide, 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (r)- but generally known as brinzolamide, which bears US NIH Compound Identifier 68844. European Medicines Agency schedules Brinzolamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05892MIG.

UNSPSC 51241104 Brinzolamide is a Commodity code covering procurement of this topical carbonic anhydrase inhibitor ophthalmic medication, used primarily to treat elevated intraocular pressure in glaucoma and ocular hypertension. State and local governments purchase brinzolamide through pharmacy benefit programs, correctional health services, public health departments, and institutional care settings including state hospitals, county jails, and municipal clinics. The medication is typically procured as a branded or generic suspension formulation in standard concentrations, often bundled within broader pharmaceutical purchasing agreements or standalone drug formulary additions. Issuing bodies span state Medicaid agencies, county health departments, prison system medical divisions, and occasionally city public health clinics, though state-level health and human services departments represent the primary buyers given the volume of covered populations and institutional facilities they serve.

The source provides no recent state or local contract opportunities or response dates for this code, limiting visibility into current geographic activity or representative recent solicitations. Brinzolamide procurement at the state and local level typically occurs through established pharmaceutical supply contracts, state group purchasing organization cooperative purchasing vehicles, or direct vendor arrangements rather than through time-bound competitive RFP or ITB processes, which may explain the absence of posted opportunities in public notice systems.